Patient action plan 'Helping patients live with neuropathic pain' references

  1. Hayes C, Naylor R, Egger G. Understanding chronic pain in a lifestyle context. Am J Lifestyle Med 2012;6:421-8.
  2. Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015;14:162-73.
  3. Neurology Expert Group. Neurology guidelines: version 4. West Melbourne: Therapeutic Guidelines Limited, 2011, 15 August 2017 (accessed 9 October 2017).
  4. Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132:237-51. 
  5. Moulin D, Boulanger A, Clark AJea. Pharmacological management of chronic neuropathic pain - revised consensus statement from Canadian Pain Society. Pain Res Manag 2014;19. 
  6. Williams AC, Eccleston C, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev 2012;11:CD007407. 
  7. Nicholson B, Verma S. Comorbidities in chronic neuropathic pain. Pain Med 2004;5 Suppl 1:S9-S27. 
  8. Streckmann F, Zopf EM, Lehmann HC, et al. Exercise intervention studies in patients with peripheral neuropathy: a systematic review. Sports Med 2014;44:1289-304.
  9. Johnson MI, Bjordal JM. Transcutaneous electrical nerve stimulation for the management of painful conditions: focus on neuropathic pain. Expert Rev Neurother 2011;11:735-53.
  10. Dimitrova A, Murchison C, Oken B. Acupuncture for the treatment of peripheral neuropathy: A systematic review and meta-analysis. J Altern Complement Med 2017;23:164-79.
  11. Esteve R, Ramírez-Maestre C, López-Martínez AE. Adjustment to chronic pain: The role of pain acceptance, coping strategies, and pain-related cognitions. Ann Behav Med 2007;33:179-88.

Fact sheet 'Amitriptyline for nerve pain' references

  1. Neurology Expert Group. Neurology guidelines: version 4. West Melbourne: Therapeutic Guidelines Limited, 2011, 15 August 2017 (accessed 9 October 2017).
  2. Cepeda MS, Farrar JT. Economic evaluation of oral treatments for neuropathic pain. J Pain 2006;7:119-28.
  3. Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015;14:162-73.
  4. O'Connor AB. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics 2009;27:95-112.
  5. Moore RA, Derry S, Aldington D, et al. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev 2015:CD008242.
  6. McQuay HJ, Carroll D, Glynn CJ. Dose-response for analgesic effect of amitriptyline in chronic pain. Anaesthesia 1993;48:281-5. 
  7. Standards of medical care in diabetes--2012. Diabetes Care 2012;35 Suppl 1:S11-63. 
  8. Western Australian Therapeutic Advisory Group. Advisory Note: Neuropathic Pain Guidelines. Perth: Department of Health, 2017 (accessed 17 August 2017).
  9. Attal N, Bouhassira D. Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms? Pain 2015;156 Suppl 1:S104-14
  10. Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132:237-51. 
  11. Australian Medicines Handbook. Tricyclic antidepressants. Adelaide: Australian Medicines Handbook Pty Ltd, 2017 (accessed 5 October 2017).